6-Chloro-1,3-benzoxazol-2-amine(CAS: 52112-68-2)

6-Chloro-1,3-benzoxazol-2-amine (CAS: 52112-68-2) is classified under the GHS (Globally Harmonized System of Classification and Labeling of Chemicals) as a hazardous substance. It is regulated under REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) in the EU, which requires registration for substances above one tonne per year. In the USA, it is subject to FDA and EPA regulations for its use in pharmaceuticals and environmental safety, respectively.

There are several alternatives to 6-Chloro-1,3-benzoxazol-2-amine (CAS: 52112-68-2) in synthesis, including 6-aminobenzoxazole and 6-methoxy-1,3-benzoxazol-2-amine. These alternatives offer similar structural and functional properties and can be used in various synthetic routes depending on the desired outcome and availability of reagents.

The market for 6-Chloro-1,3-benzoxazol-2-amine (CAS: 52112-68-2) is driven by its use in the pharmaceutical industry as an intermediate in the synthesis of anti-inflammatory and anti-tumor drugs. Research trends are focused on exploring its potential in new drug development, particularly in the treatment of diseases such as cancer and inflammatory disorders. Additionally, there is growing interest in its applications in agrochemicals.

Waste containing 6-Chloro-1,3-benzoxazol-2-amine (CAS: 52112-68-2) should be collected in appropriate containers and stored in a well-ventilated area. It should be neutralized using a suitable reagent before disposal to minimize environmental impact. Incineration is a recommended method for disposing of this waste, provided it meets the local environmental regulations. Professional waste disposal services should be used to ensure compliance with all relevant regulations and to safely manage the waste.